Cimicifuga racemosa

BLACK COHOSH ORAL HUMAN OTC DRUG

Cimicifuga racemosa is an FDA drug label for the active ingredient BLACK COHOSH manufactured by Boiron administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20230411.

Generic name
BLACK COHOSH
Manufacturer
Boiron
Product type
HUMAN OTC DRUG
Route
ORAL
Dosage form
N/A
NDC
0220-1385
Application
N/A
Label effective
20230411

Active ingredients

Cimifuga racemosa 30X (**contains 0.443 mg of the active ingredient per pellet)

Indications & Usage

Menstrual cramps improved by lying down*

Dosage & Administration

Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.

Contraindications

Not available.

Warnings

Not available.

Adverse Reactions

Not available.

More products with the same ingredient

BLACK COHOSH

Cimifuga racemosa

Boiron View label

Cimifuga racemosa

Boiron View label

Cimifuga racemosa

Boiron View label

Cimifuga racemosa

Boiron View label

Cimifuga racemosa

Boiron View label

Cimifuga racemosa

Boiron View label

Cimifuga racemosa

Boiron View label